The Neurodegenerative Disease Market is undergoing significant transformation due to advances in diagnostics, therapeutics, digital health, and personalized medicine. Market Research Future projects the market to grow from USD 73.46 billion in 2025 to USD 152.85 billion by 2035, representing a CAGR of approximately 7.6%.

One of the major trends influencing the market is the increasing use of artificial intelligence and machine learning. These technologies can support disease research, diagnostic analysis, patient monitoring, and drug discovery. Advanced imaging techniques are also becoming increasingly important for identifying neurological changes and supporting earlier diagnosis.

Personalized medicine is another emerging trend. Researchers and healthcare providers are increasingly focusing on treatment strategies based on individual patient characteristics, biomarkers, disease progression, and therapeutic responses. This approach may help improve treatment effectiveness and patient management.

Digital health solutions, including telemedicine, wearable devices, and mobile health applications, are also gaining importance. These technologies can help patients monitor symptoms remotely while allowing healthcare professionals to collect valuable information about disease progression.

The market is further supported by advancements in biologics, gene therapy, and disease-modifying treatments. Increasing collaboration between pharmaceutical companies, biotechnology firms, research institutions, and technology providers is expected to accelerate innovation.

As healthcare systems continue adopting advanced technologies, the Neurodegenerative Disease Market is positioned for continued development, with personalized care, digital solutions, and innovative therapeutics expected to remain major industry trends.